Jove
Visualize
Contact Us

Related Experiment Videos

RNA as a target for developing antivirals.

Kevin L McKnight1, Beverly A Heinz

  • 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Ind., USA. kevin.mcknight@lilly.com

Antiviral Chemistry & Chemotherapy
|July 15, 2003
PubMed
Summary

Researchers are developing novel antiviral drugs targeting viral RNA. This review covers small and large molecule therapeutics for RNA viruses like HIV and HCV, offering future directions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of high-throughput analytical methods for characterization and quantitation of rAAV genome integrity.

Molecular therapy. Methods & clinical development·2026
Same author

Characterization and quantitation of baculoviral DNA in rAAV vectors produced in Sf9 cells.

Molecular therapy. Methods & clinical development·2026
Same author

Hepatoviruses promote very-long-chain fatty acid and sphingolipid synthesis for viral RNA replication and quasi-enveloped virus release.

Science advances·2023
Same author

The atypical 'hippocampal' glutamate receptor coupled to phospholipase D that controls stretch-sensitivity in primary mechanosensory nerve endings is homomeric purely metabotropic GluK2.

Experimental physiology·2023
Same author

CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling.

Nucleic acids research·2023
Same author

Nonlytic Quasi-Enveloped Hepatovirus Release Is Facilitated by pX Protein Interaction with the E3 Ubiquitin Ligase ITCH.

Journal of virology·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • RNA structure and function knowledge is rapidly expanding.
  • RNA plays a critical role in viral diseases.
  • New technologies are being applied to design RNA-targeting antiviral drugs.

Purpose of the Study:

  • To summarize the current state of antiviral drug development targeting RNA.
  • To discuss approaches relevant to all virus infections, including HIV and HCV.
  • To postulate future directions in the field.

Main Methods:

  • High-throughput screening.
  • Molecular modeling.
  • Review of small-molecule and large-molecule therapeutics (antisense, ribozymes, interfering dsRNAs).

Main Results:

  • Several RNA-targeting antiviral molecules are under development for commercialization.
  • Approaches are applicable to a wide range of RNA viruses.
  • The field is advancing rapidly with new technologies.

Conclusions:

  • Targeting viral RNA is a promising strategy for antiviral drug development.
  • Diverse therapeutic modalities are being explored.
  • Continued research is essential for addressing unmet medical needs in viral infections.

Related Experiment Videos